Different Manifestations in Familial Isolated Left Ventricular Non-compaction: Two Case Reports and Literature Review

Hamida Al Hussein1, Hussam Al Hussein2, Valentin Stroe2

  • 1Department of Morphological Sciences, University of Medicine and Pharmacy of Târgu Mureş, Târgu Mureş, Romania.

Frontiers in Pediatrics
|August 11, 2020
PubMed

Insights

This study highlights familial left ventricular non-compaction (LVNC) in a mother and son. Despite a shared diagnosis of isolated LVNC (ILVNC), their clinical presentations and management strategies significantly differed.

Area of Science:

  • Cardiology
  • Genetics
  • Pathology

Background:

  • Left ventricular non-compaction (LVNC) is a rare cardiomyopathy stemming from arrested fetal myocardial development.
  • Isolated LVNC (ILVNC) presents a spectrum of clinical manifestations, from asymptomatic cases to severe heart failure (HF).

Observation:

  • A pediatric case of ILVNC presented with severe heart failure at 3 months, requiring heart transplantation at age 11.
  • The mother, diagnosed with ILVNC in childhood, developed heart failure and required an implantable cardioverter-defibrillator (ICD) post-partum.

Findings:

  • Echocardiography and CT angiography confirmed ILVNC with high non-compaction to compaction (NC/C) ratios in both patients.
  • Despite familial inheritance, the mother and son exhibited distinct disease severity and progression patterns.

Implications:

  • Familial ILVNC necessitates individualized treatment approaches due to variable clinical expressivity.
  • This case underscores the importance of comprehensive genetic and clinical evaluation in families with LVNC.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
244
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
356
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
316
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
293
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
124
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
218